Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast

Journal of the National Cancer Institute

Volumn 89, Issue 14, 1997, Pages 1059-1065

  Holland, Philip A ^a   Knox, W Fiona ^a   Potten, Christopher S ^b   Howell, Anthony ^b   Anderson, Elizabeth ^b   Baildam, Andrew D ^a   Bundred, Nigel J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; E 8875; ESTRADIOL; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PLACEBO; TAMOXIFEN; THYMIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; XENOGRAFT;

EID: 0030757825     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.14.1059     Document Type: Article

References (17)

1. Baum M, Ziv Y, Colleta A. Prospects for the chemoprevention of breast cancer. In: Steward HJ, Anderson TJ, Forrest APM, editors. Breast disease. New approaches. British Medical Bulletin 1991;47:492-503.
2. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932; 99:1670-74.
3. van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, et al. Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer 1992;28: 626-9.
4. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994; 73:118-24.
5. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-74.
6. Laidlaw IJ, Clarke RB, Howell A, Owen AW, Potten CS, Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not by progesterone. Endocrinology 1995; 136:164-71.
7. Fotherby K. Endocrinology of the menstrual cycle and pregnancy. In: Makin HL, editor. Biochemistry of steroid hormones. Oxford: Blackwell Scientific Publications, 1984:409-40.
8. Shimosato Y, Kameya T, Nagai K, Hirohashi S, Koide T, Hayashi P. Transplantation of human tumors in nude mice. J Natl Cancer Inst 1976;56:1251-60.
9. Shimosato Y, Kameya T, Hirohashi S. Growth, morphology, and function of xenotransplanted human tumors. Pathol Annu 1979;14:217-57.
10. Rae-Venter B, Reid LM. Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture. Cancer Res 1980;40:95-100.
11. Heuson JC, Pasteels JL, Legros N, Heuson-Stiennon J, Leclercq G. Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer. Cancer Res 1975;35:2039-48.
12. Kamel OW, Franklin WA, Ringus JC, Meyer JS. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 1989;134:107-13.
13. Meyer JS. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986;7:171-80.
14. Poller DN, Snead DR, Roberts EC, Galea M, Bell JA, Gilmore A. Estrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erB-2 oncoprotein. Br J Cancer 1993;68:156-61.
15. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 1992;69:1174-81.
16. Chaudhuri B, Crist KA, Mucci S, Malafa M, Chaudhuri PK. Distribution of estrogen receptor in ductal carcinoma in situ of the breast. Surgery 1993;113:134-37.
17. Hellman J, Harris JR, Canellos GP. Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1982:914-70.